# Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study

> **NCT07473635** · NA · RECRUITING · sponsor: **Bo Biering-Soerensen** · enrollment: 20 (estimated)

## Conditions studied

- CRPS (Complex Regional Pain Syndromes)
- CRPS (Complex Regional Pain Syndrome) Type I
- CRPS Type II

## Interventions

- **DRUG:** Perineural Incobotulinumtoxin-A 200 U

## Key facts

- **NCT ID:** NCT07473635
- **Lead sponsor:** Bo Biering-Soerensen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-07
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07473635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07473635, "Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07473635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*